2026
- Shadbahr, T, Pylväläinen, J, Eineluoto, J, Moro, A, Kerro, O, Kenttämies, A et al.. PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.03.014. PubMed PMID:42103551 .
- Mäntylä, E, Korpela, S, Rekonen, A, Hakkola, S, Karttunen, J, Pörsti, A et al.. Deep Invaginations of Nuclear Envelope Coordinate Spatial Organization of Chromatin in Epithelium. bioRxiv. 2026; :. doi: 10.64898/2026.03.10.710762. PubMed PMID:41959029 PubMed Central PMC13061027.
- Müller, DC, Murtha, AJ, Bacon, JVW, Stephenson, M, Wells, C, Vasquez-Rios, C et al.. Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer. Nat Commun. 2026;17 (1):. doi: 10.1038/s41467-026-69927-7. PubMed PMID:41760649 PubMed Central PMC13066519.
- Mäntylä, S, Nurminen, A, Huovinen, S, Jaatinen, S, Haapaniemi, T, Nurminen, R et al.. Genomic analysis of PLNTY-like tumor progression into epithelioid glioblastoma: a case report. Acta Neuropathol Commun. 2026;14 (1):35. doi: 10.1186/s40478-025-02209-3. PubMed PMID:41508055 PubMed Central PMC12874860.
- De Marco, L, Micarelli, E, Panula, J, Nikkola, J, Moilanen, L, Annala, M et al.. NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome. Mol Cancer Ther. 2026;25 (4):650-661. doi: 10.1158/1535-7163.MCT-25-0864. PubMed PMID:41232028 PubMed Central PMC13044529.
- Virtanen, T, Kwan, EM, Parekh, K, Bacon, JVW, Huang, CF, Yu, IPL et al.. Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer. Ann Oncol. 2026;37 (3):388-402. doi: 10.1016/j.annonc.2025.10.1236. PubMed PMID:41161480 .